23 Jul, 2026
According to Straits Research, the global vascular access device market size was valued at $6.12 billion in 2025 and is projected to grow from $6.55 billion in 2026 to $11.24 billion by 2034, registering a CAGR of 6.99% during the forecast period 2026–2034.
The global vascular access device market is undergoing substantial expansion, propelled by the rising incidence of chronic conditions including cancer, diabetes, and end-stage renal disease (ESRD). The increasing elderly population, which is more vulnerable to chronic illnesses, intensifies the demand for vascular access devices. Technological developments, such as incorporating antimicrobial coatings and real-time imaging guidance, improve the safety and efficacy of these devices, facilitating their implementation in clinical environments.
Furthermore, the transition to minimally invasive techniques and the proliferation of home healthcare services facilitate market expansion. Nonetheless, obstacles such as the potential for catheter-related bloodstream infections (CRBSIs) and the substantial expense of sophisticated equipment may impede market growth. However, continuous research and development initiatives to enhance device design and functionality are anticipated to generate new market opportunities.
The increasing prevalence of chronic diseases, including cancer, diabetes, and end-stage renal disease (ESRD), is a key catalyst for the vascular access device industry. Patients with these illnesses frequently have prolonged intravenous therapy, requiring dependable vascular access options. The World Health Organisation (WHO) projects that global cancer cases would increase by nearly 75% by 2050, exceeding 35 million new cases each year.
Furthermore, the ageing global population exacerbates this demand, as older individuals are more prone to chronic conditions necessitating vascular treatments. Thus, the market is positioned for continuous growth, propelled by the necessity to accommodate a burgeoning patient demographic with chronic health issues.
Emerging markets consistently offer significant growth prospects for the vascular access device sector, propelled by escalating healthcare investments, a growing incidence of chronic diseases, and advancements in healthcare infrastructure.
Countries such as India are experiencing swift expansion in the vascular access devices market within the Asia-Pacific region. This expansion is ascribed to escalating healthcare expenditures, heightened awareness of new medical technologies, and an increasing patient demographic necessitating prolonged intravenous therapy. Manufacturers exploit these opportunities by broadening their operations and customising products to satisfy regional demands. These strategic measures are anticipated to promote the utilisation of vascular access devices, improve patient care, and facilitate overall market expansion in these regions.
North America possesses the largest segment of the worldwide vascular access device market, propelled by sophisticated healthcare infrastructure, a high incidence of chronic diseases, and substantial investments in research & development. The United States significantly contributes to this domination, possessing a considerable patient population necessitating vascular access for therapies including chemotherapy, dialysis, and long-term pharmaceutical administration. The National Cancer Institute projects 2,001,140 additional cancer cases in the U.S. for 2024, signifying a considerable need for vascular access devices. The presence of significant industry participants and ongoing technology innovations has further solidified the region's dominant market position.
sales@straitsresearch.com